These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 17883992)

  • 1. The use of positive inotropes in end-of-life heart failure care.
    Nauman DJ; Hershberger RE
    Curr Heart Fail Rep; 2007 Sep; 4(3):158-63. PubMed ID: 17883992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palliative Inotrope Therapy: A Narrative Review.
    Chuzi S; Allen LA; Dunlay SM; Warraich HJ
    JAMA Cardiol; 2019 Aug; 4(8):815-822. PubMed ID: 31268467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Home Inotropes and Other Palliative Care.
    Ginwalla M
    Heart Fail Clin; 2016 Jul; 12(3):437-48. PubMed ID: 27371519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Need for hospice and palliative care services in patients with end-stage heart failure treated with intermittent infusion of inotropes.
    López-Candales AL; Carron C; Schwartz J
    Clin Cardiol; 2004 Jan; 27(1):23-8. PubMed ID: 14743852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Home Therapies in Advanced Heart Failure: Inotropes and Diuretics.
    Graffagnino JP; Avant LC; Calkins BC; Swetz KM
    Curr Heart Fail Rep; 2020 Oct; 17(5):314-323. PubMed ID: 32830304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "I Just Feel Like I Always Did": Inotropic Dependency at End of Life.
    Latimer A; Pope ND; McFarlin JM
    Am J Hosp Palliat Care; 2020 Jul; 37(7):497-502. PubMed ID: 31714150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational use of inotropic therapy in heart failure.
    Felker GM; O'Connor CM
    Curr Cardiol Rep; 2001 Mar; 3(2):108-13. PubMed ID: 11177666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inotropic therapy for heart failure: an evidence-based approach.
    Felker GM; O'Connor CM
    Am Heart J; 2001 Sep; 142(3):393-401. PubMed ID: 11526351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Palliative inotrope therapy in advanced heart failure: organization and management].
    Gorni G; Correale M; Nodari S; Sinagra G
    G Ital Cardiol (Rome); 2020 Apr; 21(4):296-302. PubMed ID: 32202562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. End-of-life options for patients with advanced heart failure.
    Goldfinger JZ; Adler ED
    Curr Heart Fail Rep; 2010 Sep; 7(3):140-7. PubMed ID: 20585999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Care processes and clinical outcomes of continuous outpatient support with inotropes (COSI) in patients with refractory endstage heart failure.
    Hershberger RE; Nauman D; Walker TL; Dutton D; Burgess D
    J Card Fail; 2003 Jun; 9(3):180-7. PubMed ID: 12815567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inotropic agents].
    Yasumura Y
    Nihon Rinsho; 2006 May; 64(5):927-33. PubMed ID: 16689376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [End-stage heart failure: quantity or quality of life?].
    Delahaye F; Mercusot A; Carra L; Gouton M
    Arch Mal Coeur Vaiss; 2005 Mar; 98(3):186-91. PubMed ID: 15816320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Palliative care in the management of heart failure].
    Weigl G
    Wien Med Wochenschr; 2008; 158(23-24):739-44. PubMed ID: 19165457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous Cardiac Inotropes in Patients With End-Stage Heart Failure: An Evolving Experience.
    Malotte K; Saguros A; Groninger H
    J Pain Symptom Manage; 2018 Jan; 55(1):159-163. PubMed ID: 29030210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of end stage heart failure.
    Friedrich EB; Böhm M
    Heart; 2007 May; 93(5):626-31. PubMed ID: 17435073
    [No Abstract]   [Full Text] [Related]  

  • 17. Current Status of Inotropes in Heart Failure.
    Ginwalla M; Tofovic DS
    Heart Fail Clin; 2018 Oct; 14(4):601-616. PubMed ID: 30266368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure).
    Stevenson LW; Miller LW; Desvigne-Nickens P; Ascheim DD; Parides MK; Renlund DG; Oren RM; Krueger SK; Costanzo MR; Wann LS; Levitan RG; Mancini D;
    Circulation; 2004 Aug; 110(8):975-81. PubMed ID: 15313942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The new concept of ''interventional heart failure therapy'': part 2--inotropes, valvular disease, pumps, and transplantation.
    Thompson KA; Philip KJ; Simsir S; Schwarz ER
    J Cardiovasc Pharmacol Ther; 2010 Sep; 15(3):231-43. PubMed ID: 20595625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outpatient parenteral inotropic therapy for advanced heart failure.
    Young JB; Moen EK
    J Heart Lung Transplant; 2000 Aug; 19(8 Suppl):S49-57. PubMed ID: 11016488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.